Together, this circulating CCL21 analyses indicate that ELISA and Luminex are not comparable methods for CCL21 in SSc, and support the notion that ELISA may be more sensitive in the concentration range of CCL21 than the multiplex assay and associated with PAH and predicts PAH in SSc. This evidence concerns the gene CCL21 and pulmonary arterial hypertension.